Review article: prevention, diagnosis and management of COVID‐19 in the IBD patient
Alimentary Pharmacology & Therapeutics2020Vol. 52(1), pp. 54–72
Citations Over TimeTop 10% of 2020 papers
Aysha Al‐Ani, Ralley Prentice, Clarissa Rentsch, Doug Johnson, Zaid Ardalan, Neel Heerasing, Mayur Garg, Sian E. Campbell, Joe Sasadeusz, Finlay Macrae, Siew C. Ng, David T. Rubin, Britt Christensen
Abstract
IBD patient management presents a challenge in the current COVID-19 pandemic. The primary focus should remain on keeping bowel inflammation controlled and encouraging medication adherence.
Related Papers
- → Adult’s Perception of Every Day Life Change After COVID-19(2022)1 cited
- → Before, During, and After COVID-19 with N-grams Analyze keyword changes for leisure: focusing on news articles from 2018 to 2023(2023)1 cited
- → ХАРАКТЕРИСТИКА ОЧАГОВ COVID-19 С РАСПРОСТРАНЕНИЕМ В ОРГАНИЗОВАННЫХ КОЛЛЕКТИВАХ, ЗАРЕГИСТРИРОВАННЫХ В ХАБАРОВСКОМ КРАЕ В ПЕРИОД С АПРЕЛЯ ПО СЕНТЯБРЬ 2020 Г.(2020)
- → COVID–19流行下における自殺企図患者の推移(Changes in suicide attempt patients during the COVID–19 pandemic)(2022)
- → Next Step in Clinical Clerkships in Anesthesiology Beyond the COVID-19 Pandemic(2023)